"As Mississippi’s only dedicated Headache Treatment center, The Headache Center has treated over 6,000 patients from not just all over Mississippi and the Southeast. In fact, some of our patients have traveled from all over the United States to be evaluated and properly diagnosed."

During the past decade, The Headache Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Headache Center" #1 sponsor was "Allergan" with 4 trials, followed by "Amgen" with 1 trials sponsored, "Cady, Roger, M.D." with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "Mayo Clinic" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Headache Center" #1 collaborator was "Avanir Pharmaceuticals" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Headache Center" are "Episodic Migraine" (4 trials), "Migraine" (2 trials) and "Migraine, With or Without Aura" (2 trials). Many other conditions were trialed in "The Headache Center" in a lesser frequency.

Most popular intervention types in "The Headache Center" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atogepant" (2 trials), "Placebo" (2 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials) and "AMG334" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Headache Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "The Headache Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in The Headache Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Headache Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".